Bank Of New York Mellon Corp Neuro Pace Inc Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.95 - $8.7 $88,481 - $155,512	-17,875 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.63 - $17.36 $3,408 - $6,857	395 Added 2.26%	17,875 $180,000
Q3 2021 Nov 12, 2021	BUY	$15.85 - $25.07 $94,798 - $149,943	5,981 Added 52.01%	17,480 $277,000
Q2 2021 Aug 11, 2021	BUY	$19.03 - $26.5 $218,825 - $304,723	11,499 New	11,499 $273,000

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $230M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.